Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-08 Kumar Rashmi Director Sale 10b5-1 −15,000 $4.46 $67K 171,889
2026-06-04 Kumar Rashmi Director Grant or award +59,701 186,889
2025-06-05 Kumar Rashmi Director Grant or award +49,796 127,188
2024-08-19 Kumar Rashmi Director Sale 10b5-1 −7,500 $28.01 $210K 77,392
2024-06-06 Kumar Rashmi Director Grant or award +15,695 84,892
2023-06-01 Kumar Rashmi Director Grant or award +15,151 69,197
2022-06-02 Kumar Rashmi Director Grant or award +17,275 54,046
2021-06-03 Kumar Rashmi Director Grant or award +12,848 36,771
2020-09-17 Kumar Rashmi Director Grant or award +23,923 23,923

Page 1 of 1 · 9 trades